Mallory N Morris

Learn More
PURPOSE Several recent studies have suggested improved clinical outcomes in diabetic men with prostate cancer who also use metformin. We explore whether metformin use is associated with improved outcomes specifically in men undergoing prostate brachytherapy. MATERIAL AND METHODS 2,298 consecutive patients underwent permanent interstitial brachytherapy by(More)
PURPOSE Periprostatic brachytherapy doses impact biochemical control. In this study, we evaluate extracapsular volumetric dosimetry following permanent prostate brachytherapy in patients entered in a multi-institutional community database. MATERIAL AND METHODS In the database, 4547 patients underwent brachytherapy (3094 - (125)I, 1437 - (103)Pd and 16 -(More)
PURPOSE To evaluate multi-institutional prostate brachytherapy dosimetric quality using multisector analysis. METHODS AND MATERIALS In the database, 4547 patients underwent brachytherapy (3094 for (125)I, 1437 for (103)Pd, and 16 for (131)Cs). The original prostate postimplant dosimetry was reported using the maximum dose covering 90% of the prostate(More)
PURPOSE To evaluate, using real-time monitoring of implanted radiofrequency transponders, the intrafraction prostate displacement of patients as a function of body mass index (BMI). METHODS AND MATERIALS The motions of Beacon radiofrequency transponders (Calypso Medical Technologies, Seattle, WA) implanted in the prostate glands of 66 men were monitored(More)
PURPOSE Achieving high-quality permanent interstitial brachytherapy in smaller prostates is thought to be more difficult than in larger glands. This study evaluates 4547 implants in a large community database to test this hypothesis. METHODS AND MATERIALS From January 2003 to October 2010, 4547 prostate brachytherapy implants from a large community(More)
  • 1